Biohaven Ltd (BHVN)
54.67
-2.35
(-4.12%)
USD |
NYSE |
Mar 28, 16:00
55.00
+0.33
(+0.60%)
After-Hours: 17:40
Biohaven Shareholders Equity (Quarterly): 427.98M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 427.98M |
September 30, 2023 | 290.01M |
June 30, 2023 | 387.26M |
March 31, 2023 | 472.26M |
Date | Value |
---|---|
December 31, 2022 | 538.77M |
September 30, 2022 | 100.22M |
June 30, 2022 | 262.23M |
December 31, 2021 | 34.69M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
34.69M
Minimum
Dec 2021
538.77M
Maximum
Dec 2022
314.18M
Average
338.63M
Median
Shareholders Equity (Quarterly) Benchmarks
Blueprint Medicines Corp | 130.61M |
Apellis Pharmaceuticals Inc | 194.52M |
Scholar Rock Holding Corp | 225.22M |
Alnylam Pharmaceuticals Inc | -220.64M |
Arrowhead Pharmaceuticals Inc | 160.41M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 513.21M |
Total Liabilities (Quarterly) | 85.24M |